1205 related articles for article (PubMed ID: 28560287)
1. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive
Shawki A; McCole DF
Cell Mol Gastroenterol Hepatol; 2017 Jan; 3(1):41-50. PubMed ID: 28174756
[TBL] [Abstract][Full Text] [Related]
3. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.
Jergens AE; Parvinroo S; Kopper J; Wannemuehler MJ
Front Med (Lausanne); 2021; 8():669913. PubMed ID: 34513862
[TBL] [Abstract][Full Text] [Related]
4. Intestinal epithelium in inflammatory bowel disease.
Coskun M
Front Med (Lausanne); 2014; 1():24. PubMed ID: 25593900
[TBL] [Abstract][Full Text] [Related]
5. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.
Luettig J; Rosenthal R; Barmeyer C; Schulzke JD
Tissue Barriers; 2015; 3(1-2):e977176. PubMed ID: 25838982
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut.
Garcia-Carbonell R; Yao SJ; Das S; Guma M
Front Immunol; 2019; 10():1094. PubMed ID: 31164887
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation.
Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C
Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262
[TBL] [Abstract][Full Text] [Related]
8. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
9. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
10. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.
Su L; Shen L; Clayburgh DR; Nalle SC; Sullivan EA; Meddings JB; Abraham C; Turner JR
Gastroenterology; 2009 Feb; 136(2):551-63. PubMed ID: 19027740
[TBL] [Abstract][Full Text] [Related]
11. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
Hering NA; Schulzke JD
Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
[TBL] [Abstract][Full Text] [Related]
13. miR-200b inhibits TNF-α-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro.
Shen Y; Zhou M; Yan J; Gong Z; Xiao Y; Zhang C; Du P; Chen Y
Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G123-G132. PubMed ID: 27979826
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
15. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases].
Zouiten-Mekki L; Serghini M; Fekih M; Kallel L; Matri S; Ben Mustapha N; Boubaker J; Filali A
Med Sci (Paris); 2013 Dec; 29(12):1145-50. PubMed ID: 24356146
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier.
Ye D; Ma I; Ma TY
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G496-504. PubMed ID: 16474009
[TBL] [Abstract][Full Text] [Related]
18. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
[TBL] [Abstract][Full Text] [Related]
19. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
Schoultz I; Keita ÅV
Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
